(Q28208696)

https://api.crossref.org/works/10.1080/10428190290033288

The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10428190290033288

Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10428190290033288

IAP family proteins--suppressors of apoptosis

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10428190290033288

Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease

21 April 2017

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

Modulation of life and death by the TNF receptor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

A novel domain within the 55 kd TNF receptor signals cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

Apoptosis control by death and decoy receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

Assignment of the human CD30 (Ki-1) gene to 1p36

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

Expression of several members of the TNF-ligand and receptor family on tonsillar lymphoid B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

High proliferative activity of Reed Sternberg associated antigen Ki-1 positive cells in normal lymphoid tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

The diagnostic significance of the CD30 (Ki-1) antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

CD30 in normal and neoplastic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

CD30 is a CD40-inducible molecule that negatively regulates CD40-mediated immunoglobulin class switching in non-antigen-selected human B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

12-O-tetradecanoylphorbol-13-acetate (TPA) downregulates expression of CD30 in erythroleukemia cell line K562.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

The restricted expression pattern of the Hodgkin's lymphoma-associated cytokine receptor CD30 is regulated by a minimal promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

Involvement of Sp1 and microsatellite repressor sequences in the transcriptional control of the human CD30 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

Immunophenotypic analysis of childhood Burkitt's lymphoma in the West Midlands 1957-1986.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

Tumor necrosis factor receptor superfamily members and their ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

CD30 ligand in lymphoma patients with CD30+ tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

Ki-1 (CD30) antigen is released by Ki-1-positive tumor cells in vitro and in vivo. I. Partial characterization of soluble Ki-1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme-linked immunosorbent assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

Soluble CD30 in early rheumatoid arthritis as a predictor of good response to second-line therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

Serum levels of soluble CD30 in chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

Soluble CD30 serum level in HCV-positive chronic active hepatitis: A surrogate marker of disease activity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

Tumor necrosis factor receptor-associated factors (TRAFs)--a family of adapter proteins that regulates life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

Structural basis for self-association and receptor recognition of human TRAF2

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

RIP2 is a novel NF-kappaB-activating and cell death-inducing kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

NF-kappaB-inducing kinase activates IKK-alpha by phosphorylation of Ser-176

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

Differential regulation of IkappaB kinase alpha and beta by two upstream kinases, NF-kappaB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

Stimulus-dependent synergism of the antiapoptotic tumor necrosis factor receptor-associated factor 2 (TRAF2) and nuclear factor kappaB pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

Activation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF) 2- and TRAF5-mediated NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

Specificities of CD40 signaling: involvement of TRAF2 in CD40-induced NF-kappaB activation and intercellular adhesion molecule-1 up-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

Two differently regulated nuclear factor kappaB activation pathways triggered by the cytoplasmic tail of CD40

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

TRAF1 is a TNF inducible regulator of NF-kappaB activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

TRAF-interacting protein (TRIP): a novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

Tumor necrosis factor alpha-induced activation of c-jun N-terminal kinase is mediated by TRAF2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

Membrane localization of TRAF 3 enables JNK activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

Tumor necrosis factor receptor-associated factor 6 (TRAF6) stimulates extracellular signal-regulated kinase (ERK) activity in CD40 signaling along a ras-independent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-kappa B, elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

Mediation of TNF receptor-associated factor effector functions by apoptosis signal-regulating kinase-1 (ASK1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

CD30/TNF receptor-associated factor interaction: NF-kappa B activation and binding specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

Binding sites of cytoplasmic effectors TRAF1, 2, and 3 on CD30 and other members of the TNF receptor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

Induction of nuclear factor kappaB by the CD30 receptor is mediated by TRAF1 and TRAF2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

Tumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF2 are involved in CD30-mediated NFkappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

CD30 induction of human immunodeficiency virus gene transcription is mediated by TRAF2

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

TTRAP, a novel protein that associates with CD40, tumor necrosis factor (TNF) receptor-75 and TNF receptor-associated factors (TRAFs), and that inhibits nuclear factor-kappa B activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

The tyrosine kinase NPM-ALK, associated with anaplastic large cell lymphoma, binds the intracellular domain of the surface receptor CD30 but is not activated by CD30 stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

Opposite effects of the CD30 ligand are not due to CD30 mutations: results from cDNA cloning and sequence comparison of the CD30 antigen from different sources

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

Impaired Negative Selection of T Cells in Hodgkin's Disease Antigen CD30–Deficient Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

The TNF receptor family member CD30 is not essential for negative selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

CD30-dependent degradation of TRAF2: implications for negative regulation of TRAF signaling and the control of cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

A murine xenograft model for human CD30+ anaplastic large cell lymphoma. Successful growth inhibition with an anti-CD30 antibody (HeFi-1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

CD30-mediated cell cycle arrest associated with induced expression of p21(CIP1/WAF1) in the anaplastic large cell lymphoma cell line Karpas 299.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

CD30 signals integrate expression of cytotoxic effector molecules, lymphocyte trafficking signals, and signals for proliferation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

Distinct effects of CD30 and Fas signaling in cutaneous anaplastic lymphomas: a possible mechanism for disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288

Production of a monoclonal antibody specific for Hodgkin and Sternberg–Reed cells of Hodgkin's disease and a subset of normal lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290033288